Maxcyte (MXCT) Change in Acquisitions & Divestments (2020 - 2026)

Maxcyte (MXCT) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $28.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 39.91% year-over-year to $28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.2 million (down 20.06% YoY) and the FY2025 annual result came in at $155.8 million, down 2.31% from the prior year.
• Change in Acquisitions & Divestments eased to $28.0 million in Q1 2026 per MXCT's latest filing, from $38.2 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $200.8 million in Q1 2022 and bottomed at $6.5 million in Q2 2022.
• The 5-year median for Change in Acquisitions & Divestments is $43.0 million (2024), against an average of $55.4 million.
• The widest annual swing landed in 2022, when Change in Acquisitions & Divestments soared 1154.97%; it then tumbled 61.29% in 2024.
• Tracing MXCT's Change in Acquisitions & Divestments over 5 years: stood at $52.5 million in 2022, then advanced by 26.19% to $66.2 million in 2023, then sank by 53.21% to $31.0 million in 2024, then climbed by 23.1% to $38.2 million in 2025, then slipped by 26.63% to $28.0 million in 2026.
• Per Business Quant, the three latest MXCT Change in Acquisitions & Divestments figures stand at $28.0 million (Q1 2026), $38.2 million (Q4 2025), and $40.0 million (Q3 2025).

Peer Comparison